Hashimoto T, Masui H, Uchida Y, Sakura N, Okimura K
Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Japan.
Chem Pharm Bull (Tokyo). 1991 Sep;39(9):2319-22. doi: 10.1248/cpb.39.2319.
To study the structure-activity relationships of neuromedin U-8 (NMU-8) (H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2) and to develop a NMU-8 antagonist, twenty-three NMU-8 analogs substituted with Gly or the corresponding D-amino acid(s) at positions 1-8 were synthesized by solid-phase techniques. On isolated chicken crop preparations, the contractile activity of the synthetic NMU-8 analogs was compared with that of NMU-8 and their antagonistic activity was assayed against NMU-8. The replacement of Phe2, Phe4, Arg5, Pro6, Arg7 or Asn8 with Gly brought about a drastic decrease of the agonistic activities. Substitution of the corresponding D-amino acid residue for Phe2, Phe4, Arg5, Pro6 or Asn8 caused a marked decrease of the agonistic activities, while the replacement of Tyr1 with D-form enhanced the activity. It was further revealed that [D-Pro6]-NMU-8 and [D-Leu3, D-Pro6]-NMU-8 exerted a non-competitive antagonistic activity against NMU-8 with x values of 5.22 +/- 0.12 and 5.34 +/- 0.09, respectively. [D-Phe2, D-Pro6]-NMU-8, [D-Arg5, D-Pro6]-NMU-8 and [D-Pro6, D-Asn8]-NMU-8 showed a very weak antagonism. The results indicated that 1) the side chain of each amino acid at positions 2, 4, 5, 6, 7 and 8 of NMU-8 is of relative importance for the expression of the contractile activity, and 2) [D-Pro6]-NMU-8 and its four analogs acted as an antagonist against NMU-8.
为研究神经介素U-8(NMU-8)(H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2)的构效关系并开发NMU-8拮抗剂,采用固相技术合成了23个在第1至8位被甘氨酸或相应D-氨基酸取代的NMU-8类似物。在离体鸡嗉囊标本上,比较了合成的NMU-8类似物与NMU-8的收缩活性,并测定了它们对NMU-8的拮抗活性。用甘氨酸取代苯丙氨酸2、苯丙氨酸4、精氨酸5、脯氨酸6、精氨酸7或天冬酰胺8会导致激动活性急剧下降。用相应的D-氨基酸残基取代苯丙氨酸2、苯丙氨酸4、精氨酸5、脯氨酸6或天冬酰胺8会使激动活性显著降低,而用D型取代酪氨酸1则增强活性。进一步研究发现,[D-脯氨酸6]-NMU-8和[D-亮氨酸3,D-脯氨酸6]-NMU-8对NMU-8表现出非竞争性拮抗活性,其x值分别为5.22±0.12和5.34±0.09。[D-苯丙氨酸2,D-脯氨酸6]-NMU-8、[D-精氨酸5,D-脯氨酸6]-NMU-8和[D-脯氨酸6,D-天冬酰胺8]-NMU-8表现出非常弱的拮抗作用。结果表明:1)NMU-8第2、4、5、6、7和8位每个氨基酸的侧链对收缩活性的表达相对重要;2)[D-脯氨酸6]-NMU-8及其四个类似物可作为NMU-8的拮抗剂。